342 hasil
Menampilkan 1–20 · 0,63 detik · RSS
Journal of Molecular and Cellular Cardiology Plus
Scopus
ISSN 2772-9761 · Elsevier · 342 artikel di indeks
-
Artikel Jurnal
RNA modifications in peripheral blood are associated with acute coronary syndrome
Acute coronary syndromes (ACS) trigger inflammatory and immune reactions, yet whether this response is associated with changes in RNA modifications remains poorly understood. We investigated global epitranscriptomic patterns in peripheral blood mononuclear cells (PBMC) from patients with…
-
Artikel Jurnal
Selective ROCK2 inhibition reduces microvascular obstruction but does not reduce myocardial infarction after ischaemia and reperfusion
Introduction: Myocardial ischaemia/reperfusion (I/R) injury causes infarction, microvascular obstruction (MVO), and haemorrhage. MVO, often driven by vasospasm, lacks effective therapy. The non-selective ROCK inhibitor fasudil, used for cerebral vasospasm, limits infarct size after myocardial I/R…
-
Artikel Jurnal
A perspective on the future of heart failure research
Heart failure is chronic condition that is diagnosed when the heart is no longer able to pump enough blood to meet the physiological needs of the body. It is a progressive condition and typically manifests early on as exercise intolerance due to insufficient cardiac output before developing into…
-
Artikel Jurnal
Response of human iPSC-cardiomyocytes to adrenergic drugs assessed by high-throughput pericellular oxygen measurements and computational modeling
Rate- and contractility-modulating drugs, such as adrenergic agonists and antagonists, are widely used in the treatment of cardiovascular conditions. Preclinical assessment of new modulators of rate, inotropy and metabolism can be aided by high-throughput (HT) methods for chronic measurements…
-
Artikel Jurnal
Systemic inflammation increases mast cell numbers in coronary arteries in patients who died from myocardial infarction
Systemic inflammation caused by infection peaks the risk of acute myocardial infarction (AMI), presumably by affecting atherosclerotic plaque (AP) stability. In this study, APs were examined in AMI patients with acute infection (AI). Four groups of AMI patients with or without AI were compared to…
-
Artikel Jurnal
CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine
CardioPharmaGENET COST Action network aims to advance personalized medicine in cardiovascular care by leveraging pharmacogenomics (PGx) to optimize drug therapies. In cardiovascular medicine, this approach is especially critical, given the significant patient variability in drug responses to…
-
Artikel Jurnal
The β1 adrenoceptor (AR) blocker metoprolol normalises βAR cascade and caveolar protein expression and restores β1AR responsiveness in failing right ventricular myocytes
Right ventricular (RV) failure is the leading cause of death in pulmonary artery hypertension (PAH) and treatments that preserve RV contractility are urgently required. β-adrenoceptor blockers (BB) are used clinically in left ventricular failure to improve β-adrenoceptor (AR) responsiveness but it…
-
Artikel Jurnal
PITX2C deficiency promotes arrhythmogenic remodelling via oxidative stress in atrial myocytes
Genetic variants upstream of the paired-like homeodomain transcription factor 2 ( PITX2 ) are the strongest risk variants associated with atrial fibrillation. However, the mechanisms downstream of PITX2 are not completely understood. Here, we explore the role of PITX2 in oxidative metabolism and…
-
Artikel Jurnal
Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy. The pathognomonic finding is the thickening of the myocardial layer, usually of the left ventricular wall. This hypertrophy is often caused by variants in genes encoding sarcomeric proteins. Additionally, non-genetic…
-
Artikel Jurnal
MicroRNAs and SGLT2 inhibitors in cardiovascular disease: Shared pathways and emerging roles
MicroRNAs are non-coding RNA sequences capable of transport outside the cell to regulate essential cellular processes. They are able to induce structural changes implicated in prevalent cardiovascular conditions such as heart failure, atherosclerosis and myocardial ischemia. SGLT2 inhibitors are…
-
Artikel Jurnal
Early cardiac proteomic profiling in a long-latency doxorubicin cardiomyopathy model exhibits sexual dimorphism for cardioprotection
Anthracycline-induced cardiotoxicity remains a major limitation in cancer therapy, with substantial inter-individual variability in susceptibility, including documented sex differences. However, the molecular basis underlying these disparities remains incompletely understood. In this study, we…
-
Artikel Jurnal
Lamin B1 loss in human cardiomyocytes is associated with nuclear shape deformation in dilated cardiomyopathy
Dilated cardiomyopathy (DCM) is a progressive heart muscle disease characterized by the enlargement of the heart's left ventricle. The aetiology of the disease can be genetic and/or environmental. Mutations in LMNA, the gene encoding for the nuclear lamina protein lamin A/C, are associated with…
-
Artikel Jurnal
Organelle network dysfunction in primary cardiomyopathy: An integrated perspective on pathogenesis and therapeutics
Primary (genetic) cardiomyopathy comprises a heterogeneous group of predominantly monogenic (genetically determined) myocardial diseases—principally hypertrophic (HCM), dilated (DCM) and restrictive (RCM) phenotypes—and must be distinguished from secondary/acquired cardiomyopathies attributable to…
-
Artikel Jurnal
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure
Aims: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardioprotective effects in heart failure (HF), yet the molecular mechanisms underlying these benefits remain incompletely understood. This study aimed to characterize cardioprotective effects of SGLT2i, changes of…
-
Artikel Jurnal
Coronary artery disease in smokers with low traditional risk burden: An exploratory analysis of potential genetic susceptibility
Background/objectives: Coronary arterial disease (CAD) poses a significant public health challenge, with tobacco as the most predominant modifiable risk factor in young individuals. Despite a strong correlation between tobacco use and CAD, many smokers remain CAD-free. This fact raises questions…
-
Artikel Jurnal
Acute sildenafil administration decreases the susceptibility to induced atrial fibrillation in sheep
Sildenafil has been shown to decrease ventricular arrhythmias. We investigated whether sildenafil could similarly decrease atrial fibrillation (AF) burden through direct effects on atrial electrophysiology. In vivo electrophysiological studies were performed in 12 anaesthetised sheep before and…
-
Artikel Jurnal
Why the septum thickens in hypertrophic cardiomyopathy
In hypertrophic cardiomyopathy (HCM), hypertrophy often disproportionately affects the interventricular septum, especially in the obstructive form (oHCM). The reasons for this septal predilection remain debated. Here, we review emerging evidence that septal hypertrophy in HCM represents a…
-
Artikel Jurnal
Lactylation in cardiac repair: Nexus and therapeutic opportunity
Lactylation is a lactate-driven post-translational modification that directly modifies lysine residues on both histone and non-histone proteins, thereby linking energy metabolism to epigenetic regulation. Its levels are dynamically orchestrated by intracellular lactate availability, as well as by…
-
Artikel Jurnal
Multicellular senescence programs in the aged heart
Cardiac aging reflects a convergence of intrinsic molecular damage and maladaptive stress responses that progressively erode myocardial resilience. Accumulating genomic instability, telomere dysfunction, chromatin remodeling, and metabolic dysregulation activate innate immune signaling and cellular…
-
Artikel Jurnal
Spatio-temporal targeting of cardiac cells with lipid nanoparticles after myocardial infarction
Ischemic heart disease remains the leading cause of morbidity and mortality worldwide. While current therapies prolong survival, they do not address underlying tissue damage. Messenger RNA (mRNA)-based therapies offer a promising alternative for repair and regeneration. However, targeted and…